Control Bionics Ltd. · ASX:CBL
Control Bionics — Bioshares Biotech Summit (July 2023)
11 slides from Control Bionics's conference presentation, Jul 24, 2023
Slide 1: Bioshares Biotech Summit
For personal use only Bioshares Biotech Summit PRESENTED BY: Jeremy Steele DATE PRESENTED: 24 July 2023 Private & Confidential. Copyright © Control Bionics 2023
Slide 2: Disclaimer
DISCLAIMER For personal use only This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter covered in it. The information in this presentation, whether written or verbal, has been prepared without taking into account the co
Slide 3: Our flagship product
For personal use only Our flagship product
Slide 4: Who is Control Bionics?
Who is Control Bionics? For personal use only ∙ Control Bionics (ASX:CBL) is a pioneer in the field of neuroelectric control by using smart algorithms to detect, synthesise and convert electromyography (EMG) signals into code which can interact with and control a broad range of electronic devices ∙
Slide 5: Our technology
Our technology For personal use only ∙ Control Bionics is a pioneer in the field of neuroelectric control by using smart algorithms to detect, synthesise and convert How it works electromyography (EMG) signals into code https://youtu.be/-nhhttps://youtu.be/-nhNLnktPCMNLnktPCM which can interact with
Slide 6: Current Uses of our technology
Current Uses of our technology For personal use only ∙ Our solutions are sold to individuals who have conditions such as Motor Neuron Disease (MND), Cerebral Palsy (CP), Multiple Sclerosis (MS) and acquired spinal injury (amongst others) that leave a user with a high degree of physical incapacity an
Slide 7: Our sales and market strategy
Our sales and market strategy For personal use only Team Sales Channels Pricing and reimbursement USA 23 Staff US sells directly to end users through relationships with speech language Dependent on the payor. Mix of payors in the 10 Sales pathologists (‘SLPs’). We also have distributors who sell our
Slide 8: Competitor Landscape
Competitor Landscape For personal use only ∙ Tobii (TDVOX on NASDAQ Nordic) based in Sweden, with a market cap of ~A$390m is the largest player in augmentative and alternate communications market. ∙ Like CBL, Tobii generates most of its revenue in the US, however has an established base in Europe as
Slide 9: Our Future Technology
Our Future Technology For personal use only R&D • Our technology development is spread across Australia and the US, leaning on both skill sets and incentives to ensure we continually enhance the technology we have, while ensuring we identify opportunities to enhance our future revenue streams DROVE
Slide 10: How good is the opportunity for Control Bionics?
HOW GOOD IS THE OPPORTUNITY FOR CONTROL BIONICS? For personal use only ∙ Control Bionics has patented EMG technology that is unique and has already demonstrated commercial viability ∙ In the first market in which it has been commercialised (AAC), we have shown that it successfully improves outcomes
Slide 11: Thank you
THANK YOU For personal use only JEREMY STEELE jsteele@controlbionics.com +65 9011 3975 www.controlbionics.com
Control Bionics — Bioshares Biotech Summit (July 2023) on 6ix